Biomarkers to Predict DMARDs Efficacy and Adverse Effect in Rheumatoid Arthritis.

ABSTRACT: Rheumatoid arthritis (RA), one of the most common immune system diseases, mainly affects middle-aged and elderly individuals and has a serious impact on the quality of life of patients. Pain and disability caused by RA are significant symptoms negatively affecting patients, and they are especially seen when inappropriate treatment is administered. Effective therapeutic strategies have evolved over the past few decades, with many new disease-modifying antirheumatic drugs (DMARDs) being used in the clinic. Owing to the breakthrough in the treatment of RA, the symptoms of patients who could not be treated effectively in the past few years have been relieved. However, some patients complain about symptoms that have not been reported, implying that there are still some limitations in the RA tre

SUBMITTER: Wei K 

PROVIDER: S-EPMC8995470 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature